首页 | 本学科首页   官方微博 | 高级检索  
     

卡介菌多糖核酸的临床应用进展
引用本文:周玉成[综述] 周雅丽[综述]. 卡介菌多糖核酸的临床应用进展[J]. 中国医学文摘:老年医学, 2009, 0(5): 482-484
作者姓名:周玉成[综述] 周雅丽[综述]
作者单位:玉林市结核病防治所,广西537028
摘    要:卡介菌多糖核酸为一种新型的非特异性免疫调节剂,临床应用广泛。本文就卡介菌多糖核酸在小儿哮喘发作、过敏性咳嗽、反复呼吸道感染、慢性阻塞性肺疾病、慢性肺心病、肺结核、结核性胸膜炎、晚期肺癌及免疫病理反应疾病等疾病中的应用进展作一综述。

关 键 词:卡介菌多糖核酸  临床应用

Progress on clinical application of bacillus calmette- guerin ribonucleic acid
Affiliation:ZHOU Yu- cheng,ZHOU Ya- li.( Yulin Tuberculosis Prevention and Cure Institute, Guangxi 537028, China)
Abstract:Bacillus calmette - guerin ribonucleic acid is a newtype of non - specific immunity regulatire drug, and has been widely used in clinic. This article reviews the advances of clinical application of bacillus calmette -guerin ribonucleic acid in the children asthma attack, henoch- schonlein cough, recurrant respiratory tract infection, chronic obstructie pulmonary disease( COPD), chronic pulmonary heart disease, pulmonary tuberculosis, tuberculosis pleurisy,late pulmonary carcinoma and immunity pathergy disease,etc.
Keywords:Bacillus calmette -guerin ribonucleic acid  Clinical application
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号